Navigation Links
Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23
Date:2/11/2008

Seventy-nine Percent of U.S. Oncologists Currently Use Avastin to Treat the

Disease, According to a New Macroview Update from Decision Resources

WALTHAM, Mass., Feb. 11 /PRNewswire/ -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, reports that the FDA's Oncologic Drugs Advisory Committee (ODAC) voted against Genentech/Roche's Avastin for first-line treatment of breast cancer in December 2007. According to the new Macroview update, the FDA's ODAC voted 5 to 4 that data are insufficient to recommend Avastin for approval for first-line treatment of metastatic or recurrent breast cancer.

The ODAC said that in the absence of a benefit in overall survival, Avastin's 5.5 month improvement in progression-free survival does not outweigh the risks associated with the drug.

An August 2007 survey by Decision Resources found that a very high rate of oncologists prescribing Avastin off-label to treat metastatic breast cancer.

"In August of 2007, 79 percent of U.S. oncologists were using Avastin to treat breast cancer patients," said Mary Fletcher-Louis., director at Decision Resources. "This prescribing behavior is driven by familiarity with Avastin for colorectal cancer and non-small-cell lung cancer, and by approval of this agent for breast cancer in Europe."

The FDA is not bound by the ODAC vote, and will make its final decision by February 23, 2008. For commentary on the final vote, please contact Elizabeth Marshall at 781-296-2563 to schedule an interview with Dr. Argent-Katwala.

About Macroview from Decision Resources

Macroview is the most up-to-date analysis on events impacting the healthcare industry. The Macroview updates are part of Decision Resources' Pharmaview product line, which offers a thorough analysis of the biopharmaceutical sector from a therapy, industry and company point-of-view.

About Decision Resources

'/>"/>
SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Despite polarized opinions, Democrats and Republicans perform same amount of green actions
2. Physicians Still Hopeful About Desmoteplase for the Treatment of Acute Ischemic Stroke Despite Negative Results
3. Herons persist in Chicago wetlands despite exposure to banned chemicals
4. Despite efforts, significant racial disparities in cancer therapy still exist
5. Coshocton County Memorial Hospital RNs to Strike Despite Hospitals Claim of Financial Hardship
6. Miscarriage myths persist despite prevalence of medical information
7. Research finds allergic children exposed to peanuts at younger ages despite recommendations to avoid
8. Enrollment Growth Slows at U.S. Nursing Colleges and Universities in 2007 Despite Calls for More Registered Nurses
9. A Full and Long Life, Despite Diabetes
10. Plastic Surgery Complications and Deaths are Rare, Despite Highly Publicized Death of Donda West
11. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...ble in German . , One of the defining cha...ically prevent programmed cell death (apoptosis), ...iferation of defective cells. In order to do this,...) among other proteins. , Many of the cancer dr...Ps, since if the levels of IAPs are reduced, tumou...
(Date:12/1/2008)...AF,s National Legislative Team, Response to Issues..., WASHINGTON, Dec. 1 ... a national, non-profit organization dedicated to ...t access to healthcare through public policy refor...ay the appointment of Grayson Fowler to Vice Presi...
(Date:12/1/2008)...r orthopaedic surgeon is the driving force for a s...l., Dec. 1 /PRNewswire-USNewswire/ - - While many...ny musculoskeletal injury may be anxious to get ba... to get behind the wheel of a car can be a difficu...he concerns of orthopaedic surgeons and patients a...
(Date:12/1/2008)...ber 1 Mentice proudly announces,t...ulation training - the,Mentice VIST 7.7 enhanced ...ntions. New features such as vital signs, complica...tionality add to the clinical realism and,enhance... "Features like vital signs and complications...
Breaking Medicine News(10 mins):Health News:Surprise discovery made in cancer research 2Health News:National Patient Advocate Foundation (NPAF) Announces New Executive Vice President of Federal Legislative Affairs 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 2Health News:When to Get Back Behind the Wheel While on the Road to Recovery 3Health News:Mentice VIST(TM) New and Enhanced Carotid and Coronary Training Modules Take Medical Simulation Training to the Next Level 2
... who suffers from AIDS Wednesday inaugurated a uni...doms// as its theme. Pooja Thakur, who discovere...e in October 2005, said she was thrilled to be ina...- said to be the country's first. The unique bar...
...ow that older women - those 80 or older - have the...ng to new research// published today. Worryingly,... wrongly believed that age does not affect breast ... risk factor for breast cancer - after gender -is ...
...n optician who was part of a British charity, made...nteering// in India. Premal Patel, who was part o...y, carried out a record 850 eye examinations in a ...angalore in March. The charity helps people with ...
... autistic children are no more likely than other c... research. Researchers compared blood samples of ...without autism who had been referred to an outpati...looked for two antibodies used to help detect celi...
Other Medicine News:Health News:India’s First ‘condom Bar’ Inaugurated by AIDS Pati 2Health News:Women Unaware of When Breast Cancer Risk is Greatest 2
(Date:12/1/2008)...s still the best policy , , ROCHESTER, Min...from Mayo Clinic finds the use of the drug therapy...titis, an acute inflammation of the liver caused b... the study are published in the December issue of ... ). , , VIDEO ALERT: Additional audio and ...
(Date:12/1/2008)...RNewswire-FirstCall/ -- GeoVax Labs, Inc.,(OTC Bu...y company developing,human vaccines for diseases ...,other infectious agents, announced today that th...l take place in twelve sites across North and Sout...ation with The National Institutes of,Health (NIH...
(Date:11/28/2008)...any, November 28 German biotech co...n specialized HIV monitoring and,AIDS patient fol...ntries. In,the year 2008, 2.5 million patient tes...and highly affordable "CyFlow" system, supporting ...V/AIDS. Due to introduction of the,Partec innovat...
(Date:11/26/2008)...ion density, automation and intelligent clinical a... to an all new level , , CHICAGO, Ill., Nov...re ( www.siemens.com/healthcare ) highlights the...(ABVS)(1), the world,s first multi-use, automated...ntific Assembly and Annual Meeting of the Radiolog...
Breaking Medicine Technology:Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Bacteria successful in cancer treatment 621 1Bacteria successful in cancer treatment 621 2Siemens Extends Tender Offer for Acquisition of Dade Behring 619 1Siemens Extends Tender Offer for Acquisition of Dade Behring 619 2Actavis Launches Carvedilol Tablets in the U S 617 1Actavis Launches Carvedilol Tablets in the U S 617 2New knock out gene model provides molecular clues to breast cancer 615 1New knock out gene model provides molecular clues to breast cancer 615 2New knock out gene model provides molecular clues to breast cancer 615 3
... Tenn.--(BUSINESS WIRE)--May 25, 2007 - GTx, Inc.,... recent Phase II proof of,concept clinical trial o...ical trial evaluating ACAPODENE(R) (toremifene cit...ects of androgen,deprivation therapy (ADT) will be...the American Society of Clinical Oncology being,he...
..., Calif.--(BUSINESS WIRE)--May 24, 2007 - A new an...es are designed in ways,that inadvertently omit wo...Stanford University School of Medicine,researcher ... all,scientists that strict study eligibility crit...In reviewing data from a pool of 100,000 alcohol t...
Other Medicine Technology:GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 2Limiting Eligibility for Medical Studies Can Omit Women,African-Americans, Stanford Study Finds 3
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5.
For use in implant arthroplasty associated with comminuted fractures, or rheumatoid, degenerative or post-traumatic disease of the radial head. Designed for higher demand patients requiring superior
For connection to the bipolar output of electrosurgical generators.
This legless table has adjustable height and round post. Pad sold separately.
Medicine Products: